The prognostic value of plasma galectin-3 in chronic heart failure patients is maintained when treated with mineralocorticoid receptor antagonists.
Galectin-3 (Gal-3) is considered as a myocardial fibrosis biomarker with prognostic value in heart failure (HF). Since aldosterone is a neurohormone with established fibrotic properties, we aimed to investigate if mineralocorticoid receptor antagonists (MRAs) would modulate the prognostic value of G...
Main Authors: | François Koukoui, Franck Desmoulin, Michel Galinier, Manon Barutaut, Celine Caubère, Maria Francesca Evaristi, Gurbuz Murat, Rudolf De Boer, Matthieu Berry, Fatima Smih, Philippe Rouet |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4364698?pdf=render |
Similar Items
-
Some observations on the activities of mineralocorticoids and mineralocorticoid antagonists
by: Huston, G. J.
Published: (1979) -
Mineralocorticoid Receptor Antagonists
by: Ilaria Spoletini, et al.
Published: (2019-01-01) -
Metabonomics analysis of plasma reveals the lactate to cholesterol ratio as an independent prognostic factor of short-term mortality in acute heart failure.
by: Franck Desmoulin, et al.
Published: (2013-01-01) -
Blood signature of pre-heart failure: a microarrays study.
by: Fatima Smih, et al.
Published: (2011-01-01) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021-06-01)